11:10 AM EDT, 06/05/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher Wednesday morning, rising 0.93% to 1,436.34 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 3.1% and 2.8% respectively. They were followed by biotech firm BioNTech (BNTX) and 3D printer company Materialise (MTLS), which were up 1.8% and 1.6% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and hotel booking site trivago (TRVG), which lost 2.1% and 1.8% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical company Calliditas Therapeutics ( CALT ) , which fell 1.6% and 1.4% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Amarin ( AMRN ) , which climbed 8.1% and 5.2% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Adaptimmune Therapeutics ( ADAP ) , which were up 5.1% and 4% respectively.

The decliners from the UK and Ireland were led by utilities company National Grid ( NGG ) and financial services firm Lloyds Banking Group ( LYG ) , which fell 2.3% and 2.1% respectively. They were followed by biopharmaceutical firm Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company Avadel Pharmaceuticals ( AVDL ) , which were down 2% and 1.9% respectively.